Evidence map›Paper›PMID 25250012›Full record

ReviewFrontiers in neurology2014

Aluminum-induced amyloidogenesis and impairment in the clearance of amyloid peptides from the central nervous system in Alzheimer's disease.

Yuhai Zhao, James M Hill, Surjyadipta Bhattacharjee, Maire E Percy, Aileen I D Pogue, Walter J Lukiw

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Epigenetics in Alzheimer's Disease.Frontiers in aging neuroscience · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Aluminum in neurological disease - a 36 year multicenter study.Journal of Alzheimer's disease & Parkinsonism · 2019
    Article
  11. TREM2 in Neurodegenerative Diseases.Molecular neurodegeneration · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuhai ZhaoLSU Neuroscience Center, Louisiana State University Health Sciences Center, Louisiana State University , New Orleans, LA , USA ; Department of Ophthalmology, Louisiana State University Health Sciences Center, Louisiana State University , New Orleans, LA , USA.
James M HillLSU Neuroscience Center, Louisiana State University Health Sciences Center, Louisiana State University , New Orleans, LA , USA ; Department of Ophthalmology, Louisiana State University Health Sciences Center, Louisiana State University , New Orleans, LA , USA ; Department of Microbiology, Louisiana State University Health Sciences Center, Louisiana State University , New Orleans, LA , USA.
Surjyadipta BhattacharjeeLSU Neuroscience Center, Louisiana State University Health Sciences Center, Louisiana State University , New Orleans, LA , USA.
Maire E PercyDepartment of Physiology, University of Toronto , Toronto, ON , Canada ; Department of Obstetrics and Gynaecology, University of Toronto , Toronto, ON , Canada ; Neurogenetics Laboratory, Surrey Place Centre , Toronto, ON , Canada.
Aileen I D PogueAlchem Biotech , Toronto, ON , Canada.
Walter J LukiwLSU Neuroscience Center, Louisiana State University Health Sciences Center, Louisiana State University , New Orleans, LA , USA ; Department of Ophthalmology, Louisiana State University Health Sciences Center, Louisiana State University , New Orleans, LA , USA ; Alchem Biotech , Toronto, ON , Canada ; Department of Neurology, Louisiana State University Health Sciences Center , New Orleans, LA , USA.

Funding

OCULAR HSV: LATENCY, REACTIVATION, &RECURRENCER01EY006311 · NEI · LSU HEALTH SCIENCES CENTER · PI HILL, JAMES M · 1985 to 2012
$5.3M
microRNA (miRNA) signaling in Alzheimer's disease(AD)R01AG038834 · NIA · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G. · 2011 to 2020
$3.3M
NEI NIH HHS R01 EY006311NIA NIH HHS R01 AG038834
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aluminumAlzheimer’s diseaseamyloidogenesisAβ42 peptide monomersphagocytosisTREM2

Identifiers

PMID25250012
PMCPMC4155793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.